Viking Therapeutics VKTX Total Liabilities
Total Liabilities at other companies
Other financials
Where this comes from
Reported directly by Viking Therapeutics in its filing.
Tagged under the XBRL concept us-gaap:Liabilities.
The official record: Viking Therapeutics’s 10-Q, filed April 30, 2026, on SEC EDGAR. View the filing →
Ask your AI about Viking Therapeutics's total liabilities.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Viking Therapeutics's total liabilities?
- Viking Therapeutics (VKTX) reported total liabilities of $106.33M in Q1 2026.
- How has Viking Therapeutics's total liabilities changed year-over-year?
- Viking Therapeutics's total liabilities increased by 429.6% year-over-year, from $20.08M to $106.33M.
- What is the long-term trend for Viking Therapeutics's total liabilities?
- Over 5 years (2020 to 2025), Viking Therapeutics's total liabilities has grown at a 44.5% compound annual growth rate (CAGR), from $12.16M to $76.67M.
- What does total liabilities mean?
- The sum of all current and non-current obligations — everything the company owes to creditors, employees, governments, and other stakeholders.